Yitshak Kreiss

Director General

Sheba Medical Center
FOH Founder

As Director General of Sheba Medical Center since 2016, Prof. Yitshak Kreiss is world renowned for his research in leadership and health management based on humanitarian operations he led during 25 years of service in the Israel Defense Forces (IDF). While in the IDF, he rose from combat surgeon to leadership of the Medical Corps as IDF Surgeon General and attained the rank of Brigadier General. He earned his medical degree at the Hebrew University; completed a residency in internal medicine at Sheba Medical School; and earned a Master of Health Administration from Tel Aviv University and a Master of Public Administration from Harvard University. Prof. Kreiss was cited as one of the 50 most influential Jews of 2020 by the Jerusalem Post. Under his tutelage, Sheba Medical Center has also been ranked as one of the Top 10 Hospitals in the World by Newsweek Magazine since 2019.

Prof. Robert Bell, MPA

Special Advisor to the Board

Guy’s and St. Thomas’ NHS Foundation Trust

Professor Robert Bell joined the Royal Brompton & Harefield Hospitals as Chief Executive in March 2005 from the William Osler Health Centre in Ontario, Canada, where he was President and Chief Executive Officer. In February 2021, his hospitals merged with the Guy’s & St. Thomas’s NHS Foundation Trust in London.

He has over 40 years of international experience in hospital and health services management. Additionally, he is a member of the board of directors of Imperial College Health Partners, the Institute of Cardiovascular Medicine and Science, and the heart charity, CORDA.

He previously held positions as Vice President of Health Care and Life Sciences Market Sectors, Cap Gemini at Ernst & Young Canada Inc. as well as Partner at Ernst & Young and at KPMG (Peat Marwick) in Toronto. Moreover, he served as Vice President at Hilton Universal Hospitals UK Ltd in London and at International Services, Extendicare Inc. (in London and Toronto). His other roles include Executive Director of District Health Councils in the Ministry of Health in Ontario, Treasury Board Officer of the Management Board of Cabinet for the government of Ontario and systems engineer for the Hospital for Sick Children in Toronto.

He obtained a bachelor’s degree in applied science in industrial engineering and a master’s degree in public administration.

Dr. Fabrice Brunet, MD

President and CEO

CHUM

Dr. Brunet is the President and Chief Executive Officer of Centre Hospitalier de l’Université de Montréal (CHUM) and Centre Hospitalier Universitaire Sainte-Justine since September 3, 2015. He was the CEO of Sainte-Justine since January 3, 2009. He is also the President of the University of Montreal Health Network (RUIS). He is a Professor in the Department of Pediatrics at the University of Montreal; Professor of Medicine at the University of Toronto and the University of Paris; and Professor of Management at HEC Montreal and the Business School of Paris.

His many accomplishments include the development of a clinical research program in critical care and a cardiac surgery centre in Paris; the design of a private hospital project in Saint Petersburg, Russia; and the creation of an academic critical care department in Toronto.

Dr. Brunet completed his medical studies at the Faculty of Medicine Cochin Port Royal, the University of Paris V. He is Board certified in cardiology, intensive care, and emergency medicine. Dr. Brunet went on to complete his studies in management at Paris Business School, the Public Health School of Management at Harvard, and the University of Toronto. Until his arrival at CHU Sainte-Justine, he was the Chief of the Department of Critical Care at St. Michael’s Hospital in Toronto and the Medical Director of their Telemedicine Program. He then became President and CEO of the alliance between CHUM and CHU Sainte-Justine. He has extensive experience in clinical research, education and hospital management with numerous publications in peer-reviewed journals and chapters in textbooks. His main fields of interest are knowledge management in medicine, learning healthcare network development, and improvement in global performance.

Mr. Vincent-Nicolas Delpech

CEO

North-University of Paris Hospital Group

Since February 1, 2019, Vincent-Nicolas Delpech has been CEO of the North-University of Paris Hospital Group, which includes 7 Parisian hospitals (Saint-Louis, Lariboisière – Fernand-Widal, Bichat – Claude-Bernard, Beaujon, Louis-Mourier, Bretonneau, and Robert-Debré). These employ 20,000 health professionals.

Since May 2019, he is also the chairman of RMEF (Réseau Mère Enfants de la Francophonie).

Dr. Sunil Eappen

Interim President

Brigham Health

Dr. Eappen currently serves as the interim president of Brigham Health, a role he assumed on March 1. Additionally, Eappen serves as Chief Medical Officer, where he leads key initiatives in physician recruitment and retention, medical affairs and patient care. Partnering closely with the Associate Chief Medical Officers, he will focus on developing new clinical care delivery strategies that will significantly improve efficiency, financial outcomes and, most importantly, patient outcomes.

Eappen will lead efforts focusing on integration between Brigham Health and Mass General Brigham clinicians, pharmacy management, and nurturing a culture of professionalism that extends beyond physicians and nurses to all Brigham and Women’s Hospital staff.

Eappen joined BWH on July 16, 2018, from Massachusetts Eye and Ear Infirmary, where he most recently served as the Chief of Anesthesiology and the Chief Medical Officer. He was previously the Medical Director of the Operating Rooms at Massachusetts Eye and Ear Infirmary. In these roles at the Mass Eye and Ear, he managed the Medical Staff Office and the pharmacy as well as leading the Quality and Patient Experience Programs.

Eappen earned his bachelor’s degree in mathematics and computer science from the University of Illinois at Urbana- Champaign, his MD from the University of Chicago’s Pritzker School of Medicine and an MBA from the Yale University School of Management. He completed his residency in anesthesiology at Brigham and Women’s Hospital. Eappen has numerous published articles and is a national speaker on the utility of surgical checklist implementation in order to reduce surgical complications, optimizing OR efficiency, and change management. In addition to serving as CMO, Eappen is also an Associate Professor of Anesthesia at Harvard Medical School.

Mr. Nigel Edwards

Chief Executive

Nuffield Trust

Nigel Edwards joined the Nuffield Trust as Chief Executive in April 2014. His career has been spent in health service management and health policy, focusing particularly on innovation and change in the delivery of health services in the UK and internationally.
After graduating in PPE from Oxford University, Nigel entered NHS management as a graduate trainee, and went on to work at hospital and regional level.

He has worked for the King’s Fund, KPMG’s global practice and the NHS Confederation where he was Director of Policy and later Chief Executive. He is an honorary visiting professor at the London School of Hygiene and Tropical Medicine, where he worked as Director of the London Health Economics Consortium from 1992 to 1999.

Nigel’s work and interests are wide ranging, from the development and implementation of new models of service delivery at the front line to wider health care policy in the UK and internationally. He also has a strong interest in using different disciplines to inform health policy and has been developing the Trust’s work on recent NHS history.

Nigel is the lead contact for the Nuffield Trust’s work as the UK correspondent for the European Observatory on Health Systems and Policies. He works regularly with the World Health Organization and has advised on health service reform in a number of countries including Kyrgyzstan, Moldova, Ukraine, Azerbaijan and Iraq. Nigel is a regular contributor to the BMJ, a well-known conference speaker and a widely quoted media commentator with a strong Twitter following.

Mr. David Entwistle

President and CEO

Stanford Health Care

David Entwistle is president and CEO of Stanford Health Care (SHC). He joined SHC in July 2016 with extensive executive experience at leading academic medical centers. Entwistle is a passionate advocate of precision health – tailoring a treatment to a patient’s specific disease or condition as well as focusing on prevention to empower patients to take charge of their health before they become ill.

Among the factors that attracted him to SHC are the unparalleled technologies available in Silicon Valley that help advance health care through better application of technology for individuals. According to Entwistle, SHC is extremely well-situated to be able to apply innovative technology, such as wearable devices that track activity or monitor blood glucose levels, to improve health.

Before joining SHC, he served for nine years as CEO of the University of Utah Hospital & Clinics (UUHC), the only academic medical center in the Intermountain West region. While serving at UUHC, Entwistle received the Modern Healthcare “Up and Comers Award,” for significant contributions in health care administration, management or policy.

He previously served as senior vice president and chief operating officer at the University of Wisconsin Hospital and Clinics in Madison, Wis., from 2002-2007; and as vice president of professional services and joint venture operations at City of Hope National Medical Center in Duarte, Calif. As a recognized health care thought leader, Entwistle serves on the boards of the American Hospital Association, the AAMC Council of Teaching Hospitals, the Accreditation Council for Graduate Medical Education, and Vizient. He is the past chair of the Utah Hospital Association and was appointed by the governor of Utah to the state’s Medicaid Task Force. Entwistle is an avid cyclist who enjoys both road and mountain biking, often accompanied by his teenage son. He also competes in Ironman Triathlons. He tweets at @DEntwistleSHC.

Dr. Gary Kaplan, MD, FACP, FACMPE

CEO

Virginia Mason Franciscan Health

Gary S. Kaplan, MD, FACP, FACMPE, FACPE, is currently CEO, Virginia Mason Franciscan Health & Senior Vice President, CommonSpirit. Dr. Kaplan served as chairman and CEO of the Virginia Mason Health System from 2000 to January 2021. He is also a practicing internal medicine physician at Virginia Mason.

Dr. Kaplan received a degree in medicine from the University of Michigan and is board certified in internal medicine. He is a Fellow of the American College of Physicians (FACP), the American College of Medical Practice Executives (FACMPE) and the American College of Physician Executives (FACPE). He is recognized as one of the most influential physician executives in health care.

Dr. Kaplan is chair of the National Patient Safety Foundation Lucian Leape Institute, and a past chair of both the Institute for Healthcare Improvement Board of Directors and the Seattle Metropolitan Chamber of Commerce. He was a founding member of Health CEOs for Health Reform and has held leadership positions with numerous organizations, including the Medical Group Management Association and the Washington Healthcare Forum.

During Dr. Kaplan’s tenure, Virginia Mason has received significant national and international praise for its efforts to transform health care, most notably as the leader in adapting the Toyota Production System for health care. Virginia Mason has consistently been named a Top Hospital by Leapfrog and was the Top Hospital of the Decade in 2010. In addition, Virginia Mason is the only Washington state hospital to earn an A patient safety grade every year since the grading system began.

Dr. Stephen Klasko, MD, MBA

President

Thomas Jefferson University

Dr. Stephen Klasko is a transformative leader and advocate for a revolution in our systems of healthcare and higher education. In 2020, he published “UnHealthcare: A Manifesto for Health Assurance” in which he and Silicon Valley’s Hemant Taneja describe a new future for healthcare focused on keeping people well.

As President of Philadelphia-based Thomas Jefferson University and CEO of Jefferson Health, he has steered since 2013 one of the nation’s fastest growing academic health institutions based on his vision of reimagining health care and higher education. His 2017 merger of Thomas Jefferson University with Philadelphia University creates a pre-eminent professional university that includes top-20 programs in fashion and design coupled with the first design thinking curriculum in a medical school and the nation’s leading research on empathy.

His track record of success at creating and implementing programs that are shaping the future of health care earned him a place among Fast Company’s 100 Most Creative People in Business in 2018 and Ernst & Young’s Greater Philadelphia Entrepreneur of the Year in 2018. He is also ranked #2 on Modern Healthcare’s list of Most Influential People in Healthcare. For 2018 to 2019, U.S. News & World Report ranked Thomas Jefferson University Hospital among the nation’s best in 10 specialties, and Magee Rehabilitation Hospital – Jefferson Health 13th Best Hospital in the nation for physical rehabilitation. In 2018, Jefferson was invited to join the World Economic Forum.

He is married to Colleen Wyse, a fashion leader and founder of The Philadelphia Trunk Show, and has three children: Lynne, David and Jill.

Dr. Ernst Kuipers, MD, PhD

President and CEO

Erasmus MC

Ernst Kuipers trained in gastroenterology and hepatology. He was appointed as a member of the Executive Board on 1 December 2012 and has chaired the Board since 15 March 2013. He was educated in the Netherlands (in Groningen, Enschede, Deventer and Amsterdam) and, after obtaining his PhD, spent several years working in Nashville, USA.

He was appointed as a Professor of Gastroenterology and Hepatology and head of our Department of Gastroenterology and Hepatology in 2000, and in 2006 also became head of the Department of Internal Medicine. Among many other things, he was the driving force behind the launch of the national bowel cancer screening program.

The combination of his academic interests and his managerial experience in a wide range of international organizations and committees has given him a broad outlook on both national and international issues, as indeed he needs in order to perform his duties as chair of the Board.

Mr. Wright L. Lassiter III

President and CEO

Henry Ford Health System

Wright L. Lassiter III is the President and CEO of Henry Ford Health System, overseeing the $6.6 billion integrated health system comprised of five acute care hospitals; three behavioral health facilities; a regional health plan; and a wide range of ambulatory, retail, and other health services consisting of more than 250 locations across Michigan and 33,000 employees.

Lassiter joined Henry Ford in December 2014 as President and assumed the role of President & CEO in 2016. Since his arrival, he led the Board and senior management through a comprehensive strategic planning effort to position Henry Ford for the future. Under his leadership, Henry Ford has completed two successful mergers, expanding its geographic footprint and generating an additional $1 billion in revenue. Additionally, the Henry Ford brand has expanded globally under his leadership with the 2020 opening of partner hospitals in Saudi Arabia and India. The System has significantly increased its quality and financial performance, earning top honors in several publicly reported quality programs and receiving both outlook and ratings upgrades from Moody’s and S&P services. With a major focus on collaboration, the System has inked major partnerships with a host of organizations, including the Detroit Pistons, Michigan State University, General Motors, Syapse, Acadia Healthcare, Presbyterian Villages of Michigan and Beckman Coulter.

A seasoned healthcare executive, Lassiter has 30 years of experience working in large, complex health systems, including Dallas Methodist Health System and JPS Health Network in Fort Worth, Texas. Prior to joining Henry Ford, Lassiter was CEO of Alameda Health System in Oakland, California, where he was credited with leading the expansion and turnaround of the $865 million public health system.

Cited for a commitment to finding solutions, Lassiter was named “Michiganian of the Year” in 2020 by The Detroit News and appeared in the 2020 “Top 10 Newsmakers” list by Crain’s Detroit Business for the second time in three years. His other accolades include multiple year recognitions as “100 Most Influential People in Healthcare” by Modern Healthcare, “Top 25 Minority Healthcare Executives in U.S. Healthcare” by Modern Healthcare, “Top Blacks in U.S. Healthcare” by the Johns Hopkins Center for Health Disparities Solutions, and “20 People Who Make Healthcare Better in the U.S” by HealthLeaders Magazine. In 2011, Fast Company prominently featured Lassiter’s work to rebuild Alameda Health. In addition to health industry recognition, Lassiter has received the Industry Award (2019) from Results Mentoring, the Corporate Leadership Award (2018) from National Medical Fellowships, and The Legacy Award (2014) from the Jobs and Housing Coalition. An avid community leader and advocate, Lassiter is the 2021 chair-elect for the American Hospital Association (AHA) Board of Trustees and will assume the AHA chair role in 2022, becoming the top-elected official of the national organization representing America’s hospitals and health systems.

Lassiter received his master’s degree in Healthcare Administration from Indiana University where he graduated number one in his class and completed his bachelor’s degree with honors in Chemistry from LeMoyne College.

Mr. Cameron Love, MHA

President and Chief Executive Officer

The Ottawa Hospital

Cameron Love is the President and Chief Executive Officer of The Ottawa Hospital (TOH), one of Canada’s leading academic health sciences centers. He took on this leadership role as of July 1, 2020, in an unprecedented time as Ontario’s health system adapts to a new service model in the wake of COVID-19.

Cameron is an inspirational leader, dynamic and engaging, who leads through collaboration and mutual respect. He is determined to continue building TOH’s reputation as a global leader in healthcare, research, and education, while improving the lives of people in the community, province, and country. In his mandate as CEO, Cameron aims to advance the programs and services at TOH; to help innovate new deliveries of healthcare by empowering TOH clinical teams and scientists; and to partner with patients and families in the Champlain region to deliver the best care.

The hospital’s core values of ‘Compassion, Teamwork, Commitment to Quality and Respect for the Individual,’ are bolstered by Cameron’s passion and integrity, which he has applied in the healthcare sector since 1998. Cameron served on TOH’s transitional leadership team that guided the merger of five local hospitals, leading to the creation of TOH and the integration of its programs and services across several campuses. Cameron has a Master’s in Health Administration, and training at the Wharton and Telfer Schools of Business, as well as a bachelor’s degree in Biology and Psychology. In addition, Cameron is involved in many regional and provincial initiatives, committees, and task forces, and sits on several boards that promote the health and wellbeing of the people in the region. Away from his professional life, Cameron can be found coaching his children’s minor hockey teams, downhill skiing, mountain biking, and spending time with his family.

Dr. Osnat Luxenburg, MD, MPH, MBA

Director of Medical Technology, Health Information and Innovation

Israeli Ministry of Health

Dr. Osnat Luxenburg is the Director of the Medical Technology, Health Information, Innovation and Research Directorate at the Israeli Ministry of Health. In this role, she is responsible for the regulation and licensing of all medical technologies including – pharmaceuticals, biological products, medical devices, procedures etc. She is in charge of decision-making on reimbursement at a national level (health services to be included under the National Insurance Law). Her other roles include – licensing all the hospitals and other medical facilities in Israel, the regulation of radiation protection in Israel and formulating national health policy.

The Directorate is also responsible for the health information in the Ministry including national data gathering as well as national registries such as the cancer registry. Another main activity is supporting research on a national level and promoting innovation in the biotech field in Israel.

Prof. Christoph A. Meier, MD

Director

Department of Internal Medicine at University Hospital Zurich

Prof. Christoph A. Meier is currently the Director of the Department of Internal Medicine at the University Hospital Zurich. He heads the expert panel of the Swiss Medical Board for health technology assessments, is a member of the Federal Committee for Quality and serves on the Board of the Novartis Venture Fund.

Prior to his current role, he was from 2016 until 2020 the Chief Medical Officer and deputy CEO at the University Hospital Basel, where he implemented VBHC as a management tool, including PROMs as key tools for quality management. Before 2016 he was the Chief of the Department of Internal Medicine & Specialties and a member of the Board of Directors at Triemli Hospital in Zurich, Switzerland, as well as Chief of Endocrinology and Head of the Laboratory of Molecular Endocrinology at the University Hospital Geneva.

Prof. Meier received his Medical Degree from the University of Basel in Switzerland and holds his Swiss Board Certification (FMH) in Internal Medicine and Endocrinology & Diabetology. He completed his medical residency at the University Hospital of Geneva and was a Postdoctoral Fellow at the National Institutes of Health in the Molecular, Cellular Nutritional Endocrinology Branch in Bethesda, MD (USA). Prof. Meier was also a Howard Hughes Medical Institute Physician Fellow at the Division of Genetics, Brigham and Women’s Hospital, as well as a Clinical Fellow in Endocrinology, Diabetes and Metabolism at the Massachusetts General Hospital, Harvard Medical School.

Dr. Lawrence Rosenberg, MD, PhD, MSc.

President and CEO

Integrated Health and Social Services at University Network, West-Central Montreal Health

Dr. Lawrence Rosenberg is President and CEO of the Integrated Health and Social Services University Network for West-Central Montreal (West-Central Montreal Health). Before assuming this position on April 1, 2015, Dr. Rosenberg had served since 2013 as Executive Director of the Jewish General Hospital (JGH). After joining the hospital in 2007, he spent six years as the Chief of Surgical Services.

Dr. Rosenberg is Professor of Surgery and Medicine at McGill University, where he earned a Master of Science degree and a doctorate in experimental surgery. He also completed post-doctoral studies and a surgical fellowship in transplantation at the University of Michigan, and went on to earn a Master of Engineering degree—the equivalent of an MBA for scientists and engineers—from the University of Waterloo.

Before coming to the JGH, Dr. Rosenberg served as Director of the Multi-Organ Transplant Program at the Montreal General Hospital, inaugurating McGill’s Pancreas Transplant Program and leading the team that performed the first successful liver transplant at McGill.

A widely acknowledged expert in the field of islet cell regeneration, Dr. Rosenberg has received many career awards, including a Chercheur National Award from the Government of Quebec. He remains the only Canadian to have received the prestigious American Surgical Association Foundation Fellowship, and he has served as a consultant to the Juvenile Diabetes Research Foundation, the Canadian Diabetes Association, the Canadian Institutes for Health Research, and the National Institutes of Health.

Dr. Paul Rothman, MD

Chief Executive Officer and Vice President

Medicine at Johns Hopkins Medicine

Dr. Paul Rothman is the dean of the medical faculty for the Johns Hopkins University School of Medicine and chief executive officer of Johns Hopkins Medicine, a $9 billion academic medical enterprise and health system with a global reach. As dean/CEO, Dr. Rothman oversees both the Johns Hopkins Health System and the school of medicine. A rheumatologist and molecular immunologist, he came to Johns Hopkins in 2012, after serving as dean of the Carver College of Medicine at the University of Iowa. Previously, he served as head of internal medicine at the University of Iowa, and prior to that, as vice chairman for research and founding director of the Division of Pulmonary, Allergy and Critical Care Medicine at Columbia University College of Physicians and Surgeons, where he joined the faculty in 1990.

A 1980 Phi Beta Kappa graduate of the Massachusetts Institute of Technology, Rothman received his Medical degree from Yale University in 1984, earning a place in the Alpha Omega Alpha Honor Medical Society. He then trained at Columbia-Presbyterian Medical Center in internal medicine and rheumatology and accepted a postdoctoral fellowship at Columbia University prior to joining its medical school faculty. Rothman’s research focused on immune system molecules, known as cytokines. Specifically, he investigated the role these molecules play in the normal development of blood cells, as well as the abnormal development of these blood cells that leads to leukemia. Dr. Rothman is a member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Society for Clinical Investigation. He served as president of the Association of American Physicians; was elected as a fellow of the American Association for the Advancement of Sciences; and is the current president of the Society of Medical Administrators. In addition, Dr. Rothman serves on the boards of Merck, as well as the King Faisal Specialty Hospital, for which he receives compensation.

Dr. Kevin Tabb, MD

President and CEO

Beth Israel Lahey Health

As President and Chief Executive Officer of Beth Israel Lahey Health (BILH), Kevin Tabb, MD, is responsible for leading a comprehensive integration plan among the BILH member organizations to effectively deliver on the promise to offer patients and their families better and broader access to extraordinary individualized care. Previously, Kevin was the Chief Executive Officer of the Beth Israel Deaconess system and Beth Israel Deaconess Medical Center (BIDMC).

Before coming to BIDMC, Kevin was Chief Medical Officer at Stanford Hospital & Clinics in Stanford, California. There, he had broad strategic and operational responsibilities, which included physician network strategy, clinical quality and patient safety initiatives, regulatory and medical staff affairs, and graduate and continuing medical education. He was previously Chief Quality and Medical Information Officer at Stanford. Prior to joining Stanford, Kevin led the Clinical Data Service Division of GE Healthcare IT.

Raised in Berkeley, California, Kevin emigrated to Israel at the age of 18 and served in the Israel Defense Forces, the country’s military service. He received his undergraduate degree from Hebrew University in Jerusalem and his MD from the Hebrew University Hadassah Medical School. He completed his residency in internal medicine at Hadassah Hospital.

Kevin resides with his family in Newton.

Dr. Shantanu Agrawal, MD

Chief Health Officer

Anthem, Inc.

Dr. Shantanu Agrawal is the Chief Health Officer of Anthem, Inc. A board-certified emergency medicine physician who has worked in both academic and community settings, Dr. Agrawal is the former Deputy Administrator for the Centers for Medicare & Medicaid Services (CMS) and Director of one of its largest centers, the Center for Program Integrity (CPI).

At CMS, Dr. Agrawal led an effort to improve the physician experience with Medicare. He also was one of the main architects of CMS’s strategy and action plan to address the national opioid epidemic. His main focus at CPI was lowering the cost of care through the detection and prevention of waste, abuse, and fraud in the Medicare and Medicaid programs. From 2012 through 2016, CPI’s prevention efforts saved Medicare and Medicaid over $50 billion.

Dr. Agrawal has testified numerous times before Congress and is a frequent national speaker on healthcare quality and value. He is a well-published author with articles in Journal of the American Medical Association, New England Journal of Medicine, Annals of Emergency Medicine, among others. He has served on numerous national committees, including for the Veterans Administration, National Academy of Medicine, and the U.S. Department of Health and Human Services.

Dr. Agrawal completed his undergraduate education at Brown University, medical education at Weill Medical College of Cornell University, and clinical training in Emergency Medicine at the Hospital of the University of Pennsylvania. He has a master’s degree in Social and Political Sciences from Cambridge University.

Dr. David Bates, MD, MS

General Internal Medicine Chief

Brigham & Women’s Hospital

Dr. Bates is an internationally renowned expert in patient safety, using information technology to improve care, quality-of-care, cost-effectiveness, and outcomes assessment in medical practice. He is a Professor of Medicine at Harvard Medical School and a Professor of Health Policy and Management at the Harvard T.H. Chan School of Public Health, where he co-directs the Program in Clinical Effectiveness. He directs the Center for Patient Safety Research and Practice at Brigham and Women’s Hospital and serves as external program lead for research in the World Health Organization’s Global Alliance for Patient Safety.

He is the immediate past president of the International Society for Quality in Healthcare (ISQua) and the editor of the Journal of Patient Safety. He serves as the principle investigator of the Health Information Technology CERT. He has been elected to the Institute of Medicine, the American Society for Clinical Investigation, the Association of American Physicians, and the American College of Medical Informatics. Furthermore, he was chairman of the Board of the American Medical Informatics Association. He has published over 700 peer-reviewed papers and has an h-index of 115, which ranks him among the 400 most cited biomedical researchers of any type.

Dr. Scott Dulchavsky, MD

Chief of Surgery and CEO of the Innovation Institute

Henry Ford Health System

Dr. Dulchavsky is currently a professor of surgery, molecular biology, and genetics at Wayne State University School of Medicine. He serves as the Roy D. McClure Chairman of Surgery and the Surgeon in Chief at Henry Ford Health System in Detroit, Michigan as well as the CEO of The Innovation Institute at Henry Ford Hospital.

He completed a PhD in Molecular Biology and Genetics at Wayne State University, where he investigated the use of gene therapy to improve wound healing in disease states. He also has served as research mentor to over 20 post-doctoral fellows and is a principal investigator for NASA and for the National Space Biomedical Research Institute in Houston, Texas. His research focus involves teaching ultrasound to the astronaut and cosmonaut crews of the International Space Station to use for medical emergencies and on medical care of exploration class spaceflight.
Dr. Dulchavsky has been elected to numerous professional organizations and national positions, including the Society of University Surgeons, Society of Critical Care Medicine, Central Surgical Society, American Association for the Surgery of Trauma, the Society of Clinical Surgery, and the American Surgical Association. He is on the White House Medical Team that provides regional care for the President of the United States.

Dr. David Feygin, PhD, MBA

Chief Digital Health Officer

Boston Scientific

As Chief Digital Health Officer, David leads Boston Scientific’s Digital Health and Data Solutions strategy and chairs the cross-functional Digital Health Council and Digital Accelerator and Growth Broad. David is responsible for establishing and leading the Digital Health Studios, Big Data, Internet of Things, Advanced Analytics and Mobility teams, and partnering internally and externally to establish the evolving capabilities that will ensure enterprise success in Digital Health. Through the pandemic, David has focused on driving Tele-First digital care solutions that enable Boston Scientific, patients and health systems to safely deliver care.

Prior to joining Boston Scientific, David served as Vice President of Health IT Integration and Strategic Innovation at Becton Dickinson (BD), where he led enterprise-wide health information technology capability development efforts to ensure commercial success and developed actionable strategies to improve patient outcomes, drive health system efficiency and enable BD’s growth through the application of information technology. As Vice President of Corporate Strategic Innovation at BD, David was responsible for integrating company-wide activities focused on the identification of new market opportunities outside of existing core areas, the development of high-impact growth concepts that fall outside of, or cut across, existing business units and incubation of non-core offerings.

David is Chair of the Executive Council for The Center for Patient Safety Research and Practice, a thought leader in information-enabled healthcare safety with a primary focus on medication error and patient safety research. David is currently serving on the Governance Committee for the National Evaluation System for Health Technology Coordinating Center (NESTcc). David received a Ph.D. in Mechanical Engineering from U.C. Berkeley for his work in virtual environments and medical simulation. He spent four years at medical simulator startups leading the development, commercialization and launch of state-of-the-art simulators including the Virtual I.V.TM product line. He also received an M.B.A. from the Harvard Business School.

Dr. Peter Fitzgerald, MD, PhD

Director of the Cardiovascular Technology Center

Stanford Medical School

Dr. Peter Fitzgerald is Director of the Center for Cardiovascular Technology at Stanford University Medical School, and Co-founder/Managing Partner at Triventures. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor Emeritus in the Departments of Medicine and Engineering at Stanford.

He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. Peter has been principal/founder of 24 healthcare companies in Silicon Valley, has transitioned 18 of these start-ups to medium/large-cap life science companies and remains on several of their advisory boards. He has been a consultant for the FDA for the past 15 years focused on medical technology and more recently, digital health.

Prior, Peter was a co-founding partner of LVP capital in San Francisco, deriving his experience in venture capital from three funds focused on medical device and biotechnology start-ups. Peter is co-founder and managing partner of Triventures and heads the US office.
Peter currently participates on the boards of: Cala Health, Cathworks, Day Zero Diagnostics, FemSelect, Genoox, HealthReveal, V-wave. Past Triventures’ portfolio companies where Peter participated on the boards include: Apica, MST, Orthospace and Zingbox.

Dr. Alan Forster, MD

Executive Vice President, Chief Innovation and Quality Officer

The Ottawa Hospital

Dr. Alan J. Forster MD, FRCPC, MSc is a general internist; Vice President, Innovation and Quality at the Ottawa Hospital; Vice Chair, Quality and Clinical Services, Department of Medicine, Faculty of Medicine, University of Ottawa. He is a Professor of Medicine at the University of Ottawa and Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute.

His research focuses on patient safety and quality improvement. He has performed seminal work evaluating the incidence of adverse events following discharge from the hospital. This work has to lead to the development of strategies to improve care during the transition home from the hospital. He is also leading in the development of a hospital data warehouse, which will serve as a supporting infrastructure for a research program in patient safety and quality of care. He has over 160 publications in peer review journals. He has served as associated editor for several prestigious peer-review journals.

He has received several prestigious awards recognizing his work within the field of health services research, including a Career Scientist Award with the Ontario Ministry of Health and Long-Term Care and an Early Research Award and Ontario Research Fund grant from the Ontario Government’s Ministry of Research and Innovation. In addition to his significant contributions to a quality and safety program at the Ottawa Hospital, he provides ongoing scientific advice regarding the measurement of quality of care to national and international organizations, such as the Canadian Institute for Health Information, eHealth Ontario, Health Quality Ontario and the World Health Organization.

Mr. Dominique Godet

General Manager

Relyens

Holder of a DESCF (Diplôme d’Etudes Supérieures Comptables et Financières) and a graduate of EM Lyon, Dominique Godet began his career at Mazars in 1990 as an auditor and then Director of activities for the Czech Republic and Slovakia. In 1998, he joined SFP (Société Française de Production) as Finance Director. Three years later, he joined April Group and held several management positions within subsidiaries before being appointed, in 2003, Chief Financial Officer of April Group and Director of Insurance Investments.

In January 2010, he joined Sham as Deputy General Manager and, on April 19, 2010, was appointed General Manager.

In 2013, Sham acquired Sofaxis and became the Sham Group, renamed Relyens in 2019.

Dr. John Halamka, MD, MS

President

Mayo Clinic Platform

John D. Halamka, M.D., M.S., president of the Mayo Clinic Platform, leads a portfolio of platform businesses focused on transforming healthcare by leveraging artificial intelligence, connected health care devices and a network of trusted partners.
Trained in emergency medicine and medical informatics, Dr. Halamka has been developing and implementing health care information strategy and policy for more than 25 years.

Prior to his appointment at Mayo Clinic, Dr. Halamka was chief information officer at Beth Israel Deaconess Medical Center and Harvard Medical School. He is a practicing emergency medicine physician. As the International Healthcare Innovation Professor at Harvard Medical School, Dr. Halamka helped the George W. Bush administration, the Obama administration and governments around the world plan
their health care information strategies.

Dr. Halamka completed his undergraduate studies at Stanford University, earned his medical degree at the University of California, San Francisco, and pursued graduate work in bioengineering at the University of California, Berkeley. He completed his residency at UCLA-Harbor Medical Center in the Department of Emergency Medicine. He is a member of the National Academy of Medicine. Dr. Halamka has written a dozen books about technology-related issues, hundreds of articles and thousands of posts on the Geekdoctor blog. He also runs Unity Farm Sanctuary in Sherborn, Massachusetts, the largest animal sanctuary in New England.

Dr. Erik Jylling, MD, MPM

Executive Vice President

Danish Regions

In his professional career Erik has been deeply involved in planning, organizing and leading the Danish healthcare System with the view from different professional perspectives and positions – practical and political. As an MD with 25 years of practical experience in anesthesiology and intensive care medicine, a consultant, head of a department and superior leading positions at the hospital and organization level.

He was a former President for Danish Junior Doctors Association and President for The Danish confederation of professional Association from 2009 to 2013. Moreover, he served as the co-founder of The Danish Patient Safety Organization and former board member of different National Pensions Funds.

Over the years, he has been a member of a number of international interest and national governmental committees. He has written about leadership, culture, quality, and organizational aspects in the health care system. Furthermore, he gained additional skills with executive management and leadership programs at Stanford and Harvard University.

Dr. Thomas Lee, MD, MPH

Chief Medical Officer at Press Ganey Associates and Editor-In-Chief at NEJM Catalyst

Press Ganey Associates

Thomas H. Lee is Chief Medical Officer for Press Ganey, where he leads development of strategies for measuring and improving quality of care. He is also a practicing internist/cardiologist at Brigham and Women’s Hospital and on the faculty at Harvard Medical School and Harvard T.H. Chan School of Public Health.

Tom was previously Network President for Partners Healthcare System in Boston. He is Editor in Chief of NEJM Catalyst, serves on the Editorial Board of The New England Journal of Medicine, and is the author of four books, including Chaos and Organization in Healthcare, An Epidemic of Empathy in Healthcare, Eugene Braunwald and the Rise of Modern Medicine, and The Good Doctor. He is a member of the Panel of Health Advisors of the Congressional Budget Office and on the Board of Directors of HealthLeads.

Tom holds a medical degree from Cornell University Medical College and a master’s degree in epidemiology from the Harvard T.H. Chan School of Public Health. He lives in Massachusetts with his wife and three daughters.

Dr. Mark McClellan, MD, PhD

Founding Director

Duke-Margolis Center for Health Policy at Duke University

Dr. McClellan is a doctor and an economist who has addressed a wide range of strategies and policy reforms to improve health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation.

At the center of the nation’s efforts to combat the pandemic, Dr. McClellan is the co-author of a roadmap that details the steps needed for a comprehensive COVID-19 response and safe reopening of our country. His current work on responding to the COVID-19 public health emergency spans virus containment and testing strategies, reforming health care toward more resilient models of delivering care, and accelerating the development of therapeutics and vaccines. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. He also has a highly distinguished record in public service and academic research.

Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care. He has also previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury.

Dr. Ryan Noach, MD

Chief Executive Officer

Discovery Health

Dr. Ryan Noach is the Chief Executive Officer Discovery Health, appointed to this role in January 2020 after serving as Deputy CEO in the business for more than 5 years. Ryan joined Discovery Health in 2008 in the provider relations area, and became Chief Operating Officer of Discovery Health in 2009. During 2018 and 2019, Ryan was seconded to Discovery Bank, in the capacity of Deputy CEO of the Bank, to support the Banking team through the product finalization, build completion, business readiness and launch period. Ryan was previously the Chief Operating Officer and an Executive Director of the Netcare Hospital Group, having held various leadership roles across Netcare. His exposure to leadership in both the funding and provider sides of private healthcare, as well as more broadly in Banking and payments, unlocks useful insights.

Ryan qualified as a medical practitioner at Wits University in 1997 and pursued a post-graduate career in emergency medicine and disaster management. He completed the Diploma in Primary Emergency Care and attended the Executive Development Program at GIBS Business School, University of Pretoria.

Ryan thoroughly enjoyed his exposure to Banking, maximizing the opportunity to learn a new field, and gain new skills, whilst leveraging his leadership and operational experience to contribute to the Bank.

Ryan has been consistently involved in various social and entrepreneurial causes throughout his adult life. Ryan is a proud father of 4 beautiful children, and in keeping with the Discovery Vitality culture, is an exercise and healthy nutrition fanatic.

Dr. Jonathan B. Perlin MD, PhD, MSHA, MACP, FACMI

President

Clinical Operations and Chief Medical Office at HCA Healthcare

Jonathan B. Perlin is President, Clinical Operations and Chief Medical Officer, HCA Healthcare, where he leads clinicians, data scientists, and researchers in using a learning health system model for improving care at the system’s 185 hospitals and 2,200 sites of care. His team’s work has achieved national recognition for preventing elective preterm deliveries, reducing maternal mortality, increasing sepsis survival, and developing public-private-academic partnerships for improving infection prevention and treating COVID-19. Their implementation of the ”Surviving Sepsis Campaign” and a computerized algorithm has saved over 8,000 lives and was recognized as the 2019 Red Hat Innovation of the Year and also earned the John M. Eisenberg Award for National Innovation in Patient Safety. In 2021, Perlin launched the “Consortium of HCA Healthcare and Academia for Research Generation” in partnership with the Agency for Healthcare Research and Quality and multiple universities (Columbia, Cleveland Clinic, Duke, Harvard, Meharry, UMass, UCSF) to accelerate the understanding of COVID-19 and its treatment as well as to create a platform for agile research partnerships.

Prior to HCA, Dr. Perlin was Under Secretary for Health in the U.S. Department of Veterans Affairs. He is a MedPAC Commissioner; a Congressional Budget Office Health Advisor; chairs the National Quality Forum and the VA Special Medical Advisory Group; and is an elected member of the National Academy of Medicine. He serves on the Board of Meharry Medical College and has faculty appointments at Vanderbilt University as Clinical Professor of Medicine and Biomedical Informatics and at VCU as Adjunct Professor of Health Administration.

Dr. David Rhew, MD

Chief Medical Officer and Vice President

Healthcare Microsoft

Dr. David Rhew joined Microsoft’s Worldwide Commercial Business (WCB) Healthcare leadership team as the Chief Medical Officer and Vice President of Healthcare.

David joined from Samsung, where he spent six years leading the company’s healthcare efforts as Chief Medical Officer and Vice President for Enterprise Healthcare. He was recently named one of Modern Healthcare’s 50 Most Influential Clinical Executive Leaders, and also serves as an adjunct professor at the Stanford University School of Medicine.

In addition, David is a computer scientist who holds six U.S. patents related to clinical decision support systems and the interoperability and integration of data in electronic health records (EHRs). An internationally recognized digital health thought leader, David has been a driving force behind the development, validation, and deployment of digital health solutions recognized by global organizations such as the Consumer Technology Association and the Vatican’s Pontifical Council for Culture as being some of the most innovative and impactful in the industry.

David provides executive-level support, engaging in business opportunities with our customers and partners. In addition, David represents the company within the marketplace through industry events and engagements. With his cross-discipline expertise and his keen ability to engage, listen, and collaborate, David’s work with our customers and partners will ensure that Microsoft delivers the right technologies and capabilities to reimagine the industry.

Mrs. Phoebe Yang, JD

General Manager

Amazon Web Services – Healthcare

Ms. Yang is General Manager of Amazon Web Services for Healthcare. Having served in C-suite and governance roles for two other national faith-based health systems, she is committed to the mission of accessible, affordable, equitable, and excellent care. She has extensive expertise in population health, digital media, M&A and post-merger integration, and new ventures.

She served as Managing Director at Rock Water Ventures, LLC. Phoebe Yang has over 20 years of experience in digital media and health, particularly building provider-led, consumer-centric business models in complex environments for both independent and strategically embedded start-ups within both media and healthcare industries. Businesses she has built and scaled include:

Scaling a population health company to launch in 5 new markets in 18 months, covering 250,000 lives, $1.5 billion in managed care spend, and over 15,000 providers, where she also negotiated and closed the first full risk contract with a national payer.

Creating and building international supply chain business to create a global group purchasing organization that spans 7 countries in 4 continents, and projected and on track to create at least $200 million in economic value in 3 years. Leading a turn-around of a $100 million media business focused on health and wellness, including digital platforms, to unprecedented profitability after 10 years of negative OCF. Launching two new international joint ventures to provide digital services to consumers in highly regulated markets. Her previous affiliations include AOL Time Warner, Discovery Inc., Rock Water Ventures, The Advisory Board, the Federal Communications Commission, Ascension, MissionPoint Health Partners, Providence-St. Joseph Health. She is a Phi Beta Kappa graduate of the University of Virginia and Stanford University.

Björn Zoëga, MD, PhD

CEO

Karolinska University Hospital

Dr. Björn Zoëga has served as the CEO at Karolinska University Hospital in Sweden since April 2019.

Other roles that he has had are CEO of the GHP Spine Center in Sweden; COO of NextCode Health; and CEO and COO of Landspitali University Hospital in Iceland.

By training, he is an orthopedic surgeon and obtained his degree from Sahlgrenska University Hospital in Sweden.